HomeNewsIndiaVoting underway for bypolls to 1 Lok Sabha, 2 assembly seats in K'taka after seats fell vacant

Voting underway for bypolls to 1 Lok Sabha, 2 assembly seats in K'taka after seats fell vacant

By-polls to Belgaum Lok Sabha and Basavakalyan Assembly seats were necessitated following the death of Union Minister Suresh Angadi and MLA B Narayan Rao respectively due to COVID-19 in September last year.

April 17, 2021 / 08:42 IST
Story continues below Advertisement
Representative image [Shutterstock]
Representative image [Shutterstock]

Voting is underway for by-election to Belgaum Lok Sabha and Maski and Basavakalyan assembly segments in Karnataka on Saturday, poll officials said.

A total of 22,68,038 voters (including service voters) are eligible to cast their votes at 3,197 polling stations in the three constituencies where voting began at 7 am and will go on till 7 pm.

Story continues below Advertisement

Among voters from all the three segments, over 11.37 lakh are men and over 11.22 lakh are women. A total of 30 candidates are in the fray from all the three constituencies. While, Belgaum has 10 candidates, Basavakalyan and Maski have 12 and eight respectively.
Twenty-six out of the total 30 candidates are men. Among the four women include two from Basavakalyan and one each from Belgaum and Maski. Counting of votes will take place on May 2.
Bypolls are being held by following the strict COVID-19 protocols, especially social distancing, wearing masks, using hand sanitisers among others, officials said, adding the last hour is reserved for coronavirus positive patients or those with symptoms.

By-polls to Belgaum Lok Sabha and Basavakalyan Assembly seats were necessitated following the death of Union Minister Suresh Angadi and MLA B Narayan Rao respectively due to COVID-19 in September last year.
Maski seat fell vacant following the disqualification of MLA Prathapagouda Patil who had won in 2018 as the Congress candidate and is now with the BJP.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show